Post-Stroke Immunodeficiency: Effects of Sensitization and Tolerization to Brain Antigens

REFERENCES

• Macrez R, Ali C, Toutirais O, Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471–480.
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009;7:97.
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.
   PubMed Web of Science ®Google Scholar
• Cuenca-Lopez MD, Brea D, Galindo MF, Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation. Rev Neurol. 2010;51:30–40.
   PubMedGoogle Scholar
• Prass K, Dirnagl U. Glutamate antagonists in therapy of stroke. Restor Neurol Neurosci. 1998;13:3–10.
   PubMedGoogle Scholar
• Brea D, Sobrino T, Ramos-Cabrer P, Castillo J. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis. 2009;27(Suppl 1):48–64.
   PubMedGoogle Scholar
• Tuttolomondo A, Di Raimondo D, di Sciacca R, Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des. 2008;14:3574–3589.
   PubMed Web of Science ®Google Scholar
• Gourin CG, Shackford SR. Production of tumor necrosis factor-alpha and interleukin-1beta by human cerebral microvascular endothelium after percussive trauma. J Trauma. 1997;42:1101–1107.
   PubMedGoogle Scholar
• Ahmad M, Graham SH. Inflammation after stroke: mechanisms and therapeutic approaches. Transl Stroke Res. 2010;1:74–84.
   PubMedGoogle Scholar
• del Zoppo GJ. The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci. 2010;1207:46–49.
   PubMedGoogle Scholar
• Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006;66:232–245.
   PubMed Web of Science ®Google Scholar
• Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol. 2006;18:145–157.
   PubMedGoogle Scholar
• McCombe PA, Read SJ. Immune and inflammatory responses to stroke: good or bad? Int J Stroke. 2008;3:254–265.
   PubMed Web of Science ®Google Scholar
• Meisel C, Schwab JM, Prass K, Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775–786.
   PubMed Web of Science ®Google Scholar
• Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53–68.
   PubMed Web of Science ®Google Scholar
• Goehler LE, Gaykema RP, Hansen MK, Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci. 2000;85:49–59.
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 1995;2:241–248.
   PubMed Web of Science ®Google Scholar
• Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. 2005;11:973–984.
   PubMed Web of Science ®Google Scholar
• Buller KM. Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis. Clin Exp Pharmacol Physiol. 2001;28:581–589.
   PubMed Web of Science ®Google Scholar
• Fortier C. Various frontiers in neuroendocrinology. Union Med Can. 1972;101:2067–2071.
   PubMedGoogle Scholar
• Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006;79:1093–1104.
   PubMed Web of Science ®Google Scholar
• Sanders VM, Baker RA, Ramer-Quinn DS, Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997;158:4200–4210.
   PubMed Web of Science ®Google Scholar
• Borger P, Hoekstra Y, Esselink MT, Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol. 1998;19:400–407.
   PubMed Web of Science ®Google Scholar
• Felten DL. Neural influence on immune responses: underlying suppositions and basic principles of neural-immune signaling. Prog Brain Res. 2000;122:381–389.
   PubMedGoogle Scholar
• Maestroni GJ. Adrenergic regulation of haematopoiesis. Pharmacol Res. 1995;32:249–253.
   PubMed Web of Science ®Google Scholar
• Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke. 2007;38:1097–1103.
   PubMed Web of Science ®Google Scholar
• Tang Y, Shankar R, Gamelli R, Jones S. Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation. J Neuroimmunol. 1999;96:182–189.
   PubMed Web of Science ®Google Scholar
• Prass K, Meisel C, Hoflich C, Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725–736.
   PubMed Web of Science ®Google Scholar
• Woiciechowsky C, Asadullah K, Nestler D, Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808–813.
   PubMed Web of Science ®Google Scholar
• Chamorro A, Amaro S, Vargas M, Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29–35.
   PubMed Web of Science ®Google Scholar
• Klehmet J, Harms H, Richter M, Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2009;158:1184–1193.
   PubMed Web of Science ®Google Scholar
• Haddad JJ, Saade NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol. 2002;133:1–19.
   PubMed Web of Science ®Google Scholar
• Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351–1362.
   PubMed Web of Science ®Google Scholar
• Szczudlik A, Dziedzic T, Bartus S, et al. Serum interleukin-6 predicts cortisol release in acute stroke patients. J Endocrinol Invest. 2004;27:37–41.
   PubMed Web of Science ®Google Scholar
• Woiciechowsky C, Schoning B, Cobanov J, et al. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma. 2002;52:339–345.
   PubMedGoogle Scholar
• Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today. 1997;18:418–424.
   PubMedGoogle Scholar
• Barrat FJ, Cua DJ, Boonstra A, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002;195:603–616.
   PubMed Web of Science ®Google Scholar
• Smets LA, Salomons G, van den Berg J. Glucocorticoid induced apoptosis in leukemia. Adv Exp Med Biol. 1999;457:607–614.
   PubMed Web of Science ®Google Scholar
• Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996;156:4422–4428.
   PubMed Web of Science ®Google Scholar
• Franchimont D, Galon J, Gadina M, Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol. 2000;164:1768–1774.
   PubMed Web of Science ®Google Scholar
• Ramirez F, Fowell DJ, Puklavec M, et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol. 1996;156:2406–2412.
   PubMed Web of Science ®Google Scholar
• Marklund N, Peltonen M, Nilsson TK, Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med. 2004;256:15–21.
   PubMed Web of Science ®Google Scholar
• Sawchenko PE, Brown ER, Chan RK, The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res. 1996;107:201–222.
   PubMed Web of Science ®Google Scholar
• Pavlov VA, Wang H, Czura CJ, The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9:125–134.
   PubMed Web of Science ®Google Scholar
• Borovikova LV, Ivanova S, Zhang M, Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–462.
   PubMed Web of Science ®Google Scholar
• Czlonkowska A, Cyrta B, Korlak J. Immunological observations on patients with acute cerebral vascular disease. J Neurol Sci. 1979;43:455–464.
   PubMed Web of Science ®Google Scholar
• Cruse JM, Lewis RE, Bishop GR, et al. Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients. Immunol Res. 1992;11:104–116.
   PubMedGoogle Scholar
• Chamorro A, Amaro S, Vargas M, Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry. 2006;77:1279–1281.
   PubMedGoogle Scholar
• Offner H, Subramanian S, Parker SM, Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176: 6523–6531.
   PubMed Web of Science ®Google Scholar
• Huschak G, Zur Nieden K, Stuttmann R, Riemann D. Changes in monocytic expression of aminopeptidase N/CD13 after major trauma. Clin Exp Immunol. 2003;134:491–496.
   PubMedGoogle Scholar
• Hug A, Dalpke A, Wieczorek N, Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 2009;40:3226–3232.
   PubMed Web of Science ®Google Scholar
• Harms H, Prass K, Meisel C, Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 2008;3:e2158.
   PubMed Web of Science ®Google Scholar
• Wolk K, Docke WD, von Baehr V, Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood. 2000;96:218–223.
   PubMed Web of Science ®Google Scholar
• Vernino S, Brown RD, Jr., Sejvar JJ, Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828–1832.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Klehmet J, Braun JS, Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38:770–773.
   PubMed Web of Science ®Google Scholar
• Stott DJ, Falconer A, Miller H, Urinary tract infection after stroke. QJM. 2009;102:243–249.
   PubMed Web of Science ®Google Scholar
• Vermeij FH, Scholte op Reimer WJ, de Man P, Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27:465–471.
   PubMed Web of Science ®Google Scholar
• Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia. 2001;16:7–18.
   PubMed Web of Science ®Google Scholar
• Prass K, Braun JS, Dirnagl U, Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607–2612.
   PubMed Web of Science ®Google Scholar
• Jauch EC, Lindsell C, Broderick J, Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke. 2006;37:2508–2513.
   PubMed Web of Science ®Google Scholar
• van Zwam M, Huizinga R, Melief MJ, Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl). 2009;87:273–286.
   PubMed Web of Science ®Google Scholar
• Jander S, Kraemer M, Schroeter M, Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab. 1995;15:42–51.
   PubMed Web of Science ®Google Scholar
• Campanella M, Sciorati C, Tarozzo G, Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke. 2002;33:586–592.
   PubMed Web of Science ®Google Scholar
• Wang WZ, Olsson T, Kostulas V, Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol. 1992;88:157–162.
   PubMedGoogle Scholar
• Youngchaiyud U, Coates AS, Whittingham S, Mackay IR. Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents. Aust N Z J Med. 1974;4:535–538.
   PubMedGoogle Scholar
• Bornstein NM, Aronovich B, Korczyn AD, Antibodies to brain antigens following stroke. Neurology. 2001;56:529–530.
   PubMedGoogle Scholar
• Dambinova SA, Khounteev GA, Izykenova GA, Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem. 2003;49:1752–1762.
   PubMed Web of Science ®Google Scholar
• Skvortsova VI, Sherstnev VV, Konstantinova NA, Involvement of autoimmune mechanisms in development of ischemic brain damage. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105: 36–40.
   PubMedGoogle Scholar
• Skvortsova VI, Konstantinova EV, Komarov AN, et al. Crioglobulinemia in cerebral and coronal atherothrombosis. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;Suppl 15:51–56.
   PubMedGoogle Scholar
• Becker KJ, Kindrick DL, Lester MP, Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab. 2005;25:1634–1644.
   PubMed Web of Science ®Google Scholar
• Croft M, Dubey C. Accessory molecule and costimulation requirements for CD4 T cell response. Crit Rev Immunol. 1997;17:89–118.
   PubMed Web of Science ®Google Scholar
• Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 1988;239:290–292.
   PubMed Web of Science ®Google Scholar
• Bechmann I, Peter S, Beyer M, Presence of B7–2 (CD86) and lack of B7–1 (CD(80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. FASEB J. 2001;15:1086–1088.
   PubMedGoogle Scholar
• Suter T, Biollaz G, Gatto D, The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur J Immunol. 2003;33:2998–3006.
   PubMed Web of Science ®Google Scholar
• Chang RC, Chen W, Hudson P, Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J Neurochem. 2001;76:1042–1049.
   PubMed Web of Science ®Google Scholar
• Adelson JD, Barreto GE, Xu L, Neuroprotection from stroke in the absence of MHCI or PirB. Neuron. 2012;73:1100–1107.
   PubMed Web of Science ®Google Scholar
• Zierath D, Thullbery M, Hadwin J, CNS immune responses following experimental stroke. Neurocrit Care. 2010;12:274–284.
   PubMedGoogle Scholar
• Kendall GS, Hirstova M, Horn S, TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Lab Invest. 2011;91:328–341.
   PubMed Web of Science ®Google Scholar
• Becker KJ. Sensitization and tolerization to brain antigens in stroke. Neuroscience. 2009;158:1090–1097.
   PubMed Web of Science ®Google Scholar
• Carty M, Bowie AG. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem Pharmacol. 2011;81:825–837.
   PubMed Web of Science ®Google Scholar
• Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol. 2004;16:23–26.
   PubMed Web of Science ®Google Scholar
• Hedayat M, Netea MG, Rezaei N. Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis. 2011;11:702–712.
   PubMed Web of Science ®Google Scholar
• Hedayat M, Takeda K, Rezaei N. Prophylactic and therapeutic implications of toll-like receptor ligands. Med Res Rev. 2012;32(2):294–325.
   PubMedGoogle Scholar
• Rezaei N. Therapeutic targeting of pattern-recognition receptors. Int Immunopharmacol. 2006;6:863–869.
   PubMed Web of Science ®Google Scholar
• Bijani FM, Vallejo JG, Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int Rev Immunol. 2012;
   Google Scholar
• Huang YH, Haegerstrand A, Frostegard J. Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol. 1996;103:61–66.
   PubMed Web of Science ®Google Scholar
• Jiang-Shieh YF, Yeh KY, Wei IH, Responses of microglia in vitro to the gram-positive bacterial component, lipoteichoic acid. J Neurosci Res. 2005;82:515–524.
   PubMedGoogle Scholar
• Lee SJ, Lee S. Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy. 2002;1:181–191.
   PubMedGoogle Scholar
• Zanin-Zhorov A, Tal-Lapidot G, Cahalon L, Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol. 2007;179:41–44.
   PubMed Web of Science ®Google Scholar
• Manicassamy S, Ravindran R, Deng J, Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med. 2009;15:401–409.
   PubMed Web of Science ®Google Scholar
• Hilker R, Poetter C, Findeisen N, Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975–981.
   PubMed Web of Science ®Google Scholar
• Kwan J, Hand P. Infection after acute stroke is associated with poor short-term outcome. Acta Neurol Scand. 2007;115:331–338.
   PubMedGoogle Scholar
• Aslanyan S, Weir CJ, Diener HC, Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN international trial. Eur J Neurol. 2004;11:49–53.
   PubMed Web of Science ®Google Scholar
• Sansing LH, Harris TH, Welsh FA, Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol. 2011;70:646–656.
   PubMed Web of Science ®Google Scholar
• Bohacek I, Cordeau P, Lalancette Hebert M, Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinflammation. 2012;9:191.
   PubMedGoogle Scholar
• Hallenbeck J. How inflammation modulates central nervous system vessel activation and provides targets for intervention–a personal perspective. Ann N Y Acad Sci. 2010;1207:1–7.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Stengelin S, Gimbrone MA, Jr., Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989;243:1160–1165.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ruetzler C, Pandipati S, Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad Sci U S A. 2003;100:15107–15112.
   PubMed Web of Science ®Google Scholar
• Yun W, Qing-Cheng L, Lei Y, Jia-Yin M. Mucosal tolerance to E-selectin provides protection against cerebral ischemia-reperfusion injury in rats. J Neuroimmunol. 2008;205:73–79.
   PubMedGoogle Scholar
• Ishibashi S, Maric D, Mou Y, Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2009;29:606–620.
   PubMedGoogle Scholar
• Wakita H, Ruetzler C, Illoh KO, Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. J Cereb Blood Flow Metab. 2008;28:341–353.
   PubMedGoogle Scholar
• Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol. 2001;2:671–672.
   PubMedGoogle Scholar
• Balabanov R, Beaumont T, Dore-Duffy P. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res. 1999;55:578–587.
   PubMed Web of Science ®Google Scholar
• Green EA, Gorelik L, McGregor CM, et al. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA. 2003;100:10878–10883.
   PubMed Web of Science ®Google Scholar
• Miller A, Lider O, Weiner HL. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med. 1991;174:791–798.
   PubMed Web of Science ®Google Scholar
• Wolvers DA, Coenen-de Roo CJ, Mebius RE, Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol. 1999;162:1994–1998.
   PubMed Web of Science ®Google Scholar
• Frenkel D, Huang Z, Maron R, Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol. 2003;171:6549–6555.
   PubMedGoogle Scholar
• Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke. 2008;39:1575–1582.
   PubMedGoogle Scholar
• Gee JM, Zierath D, Hadwin J, Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med. 2009;1:3.
   PubMedGoogle Scholar
• Takeda H, Spatz M, Ruetzler C, Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke. 2002;33:2156–2163.
   PubMed Web of Science ®Google Scholar
• Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol. 2006;13:143–157.
   PubMed Web of Science ®Google Scholar